Pfizer

Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears
Fierce Pharma
Fri, 03/4/22 - 10:27 am
Pfizer
Canada
product recalls
Accuretic
Regeneron loses bid to scrap infringement lawsuit linked to COVID antibody cocktail
Fierce Pharma
Fri, 03/4/22 - 10:20 am
Regeneron
Pfizer
BioNTech
patents
COVID-19
legal
antibody cocktail
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Fri, 03/4/22 - 09:46 am
Shionogi
vaccines
COVID-19
Japan
Pfizer
FDA begins court-mandated release of thousands of pages on Pfizer's Covid-19 vaccine review
Endpoints
Wed, 03/2/22 - 10:15 pm
FDA
Pfizer
vaccines
COVID-19
Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag
Fierce Biotech
Wed, 03/2/22 - 12:16 pm
Pfizer
GSK
vaccines
RSV
PF-06482077
FDA
breakthrough status
Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears
Fierce Pharma
Wed, 03/2/22 - 10:06 am
Pfizer
product recalls
Inderal
Canada
Chantix
Pfizer seeks silver lining in failed C. diff vaccine trial
Pharmaforum
Wed, 03/2/22 - 10:07 am
Pfizer
vaccines
clinical trials
C. difficile
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
M&A
AbbVie
AstraZeneca
Bristol Myers Squibb
JNJ
Gilead Sciences
Jazz Pharmaceuticals
Merck
Pfizer
Sanofi
rare disease
neurology
CDC data suggest Pfizer vaccine protection holds up in kids 5-11, raising questions on earlier study
Stat
Tue, 03/1/22 - 10:30 pm
Pfizer
vaccines
pediatric
CDC
COVID-19
Pfizer fails phase 3 C. diff vaccine test but still spies possible path forward
Fierce Biotech
Tue, 03/1/22 - 10:37 am
Pfizer
clinical trials
vaccines
C. difficile
Pfizer Shot Is Far Less Effective in 5- to 11-Year-Olds Than in Older Kids, New Data Show
NY Times, NY
Mon, 02/28/22 - 12:30 pm
Pfizer
vaccines
pediatric
COVID-19
Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing
Fierce Pharma
Sun, 02/27/22 - 10:23 pm
Pfizer
JNJ
Moderna Therapeutics
COVID-19
vaccines
drug pricing
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?
Fierce Pharma
Tue, 02/22/22 - 11:17 pm
Pfizer
Astellas
prostate cancer
Xtandi
NIH
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
Fierce Biotech
Fri, 02/18/22 - 10:37 am
GSK
Pfizer
RSV
vaccines
clinical trials
FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort
Endpoints
Fri, 02/18/22 - 10:25 am
Merck
molnupiravir
FDA
Pfizer
COVID-19
antivirals
Paxlovid
Pfizer's off the hook after federal judge dismisses proposed lawsuit over Chantix recalls
Endpoints
Thu, 02/17/22 - 11:14 pm
Pfizer
legal
Chantix
class action lawsuits
product recalls
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Pfizer
AstraZeneca
vaccines
COVID-19
Roche
2 Reasons Why Pfizer Might Crush Moderna in the mRNA Market. And 1 Reason Why Moderna May Stay Ahead.
Motley Fool
Thu, 02/17/22 - 10:40 am
Pfizer
Moderna Therapeutics
MRNA
vaccines
Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.
Motley Fool
Wed, 02/16/22 - 10:46 am
Pfizer
Pharma CEOs
Albert Bourla
pandemic
vaccines
COVID-19
With FDA nods and third-shot OKs, Moderna and Pfizer boost vaccine ads – and booster messages
Endpoints
Tue, 02/15/22 - 11:24 pm
Moderna Therapeutics
Pfizer
BioNTech
COVID-19
vaccines
pharma marketing
DTC advertising

Pages